sb 203580 has been researched along with protocatechuic acid in 2 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (protocatechuic acid) | Trials (protocatechuic acid) | Recent Studies (post-2010) (protocatechuic acid) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 965 | 9 | 531 |
| Protein | Taxonomy | sb 203580 (IC50) | protocatechuic acid (IC50) |
|---|---|---|---|
| M18 aspartyl aminopeptidase | Plasmodium falciparum 3D7 | 0.4794 | |
| Xanthine dehydrogenase/oxidase | Bos taurus (cattle) | 5.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, JH; Huang, CC; Lin, HH; Wang, CJ | 1 |
| Lee, CS; Nam, YJ | 1 |
2 other study(ies) available for sb 203580 and protocatechuic acid
| Article | Year |
|---|---|
Apoptotic effect of 3,4-dihydroxybenzoic acid on human gastric carcinoma cells involving JNK/p38 MAPK signaling activation.
Topics: Adenocarcinoma; Anthracenes; Apoptosis; Cell Cycle; Enzyme Inhibitors; Humans; Hydroxybenzoates; Imidazoles; MAP Kinase Kinase 4; MAP Kinase Signaling System; Mitochondria; p38 Mitogen-Activated Protein Kinases; Pyridines; Stomach Neoplasms | 2007 |
Protocatechuic acid inhibits Toll-like receptor-4-dependent activation of NF-κB by suppressing activation of the Akt, mTOR, JNK and p38-MAPK.
Topics: Acetylcysteine; Anthracenes; Anti-Inflammatory Agents; Cell Line, Transformed; Cytokines; Humans; Hydroxybenzoates; Imidazoles; Keratinocytes; Lipopolysaccharides; MAP Kinase Kinase 4; Nitriles; Oncogene Protein v-akt; p38 Mitogen-Activated Protein Kinases; Pyridines; Signal Transduction; Sulfones; TOR Serine-Threonine Kinases | 2018 |